&nbsp;

Drugs Used:

capivasertib,

fulvestrant

Quick Link(s):

Regimen Monograph

Oct 2025

Regimen

CRBPPEME+AMIV

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

pemetrexed,

CARBOplatin,

amivantamab (Unfunded)

Quick Link(s):

Regimen Monograph

Jan 2025

Regimen

PEME+AMIV(MNT)

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

pemetrexed,

amivantamab (Unfunded)

Quick Link(s):

Regimen Monograph

Jan 2025

Guidelines and Advice

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

Status: Current
ID: MOTAC-7

Jan 2025

Guidelines and Advice

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Status: Current

Mar 2025

Drug

treosulfan

Other Name(s): Trecondyv®

Quick Link(s):

Drug Monograph

Jan 2025

Regimen

PEMB(MNT)

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - First-line Treatment of Advanced HER2-negative Esophageal, Gastric, and Esophagogastric Junction Carcinoma

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

VORA

Cancer Type:

Central Nervous System

Intent: Curative, Palliative

Drugs Used:

vorasidenib (Unfunded)

Quick Link(s):

Regimen Monograph

Mar 2025

Regimen

PIRT

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

pirtobrutinib (Unfunded)